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SUMMARY – The field of corrective dermatology has gained remarkable development in the 
past two decades. New heights in techniques and the growing interest in rejuvenation procedures 
have resulted in an increase in the number of corrective procedures all over the world. Here we pre-
sent the most frequently performed corrective procedures in dermatology today: lasers, intense pul-
sed light, fillers, botulinum toxin, chemical peeling, radiofrequency, and dermabrasion. Currently, 
the most preferable procedures are those with early visible results, short ‘down-time’ and minimal 
risk of unwanted effects. Therefore, ablative resurfacing has been mostly replaced by nonablative and 
fractional resurfacing, while fillers and botulinum toxin have been ever more employed. The best 
cosmetic results can be achieved with combination of different corrective procedures.
Key words: corrective dermatology, lasers, fillers, botulinum toxin, chemical peeling
Correspondence to: Prof. Jasna Lipozenčić, MD, PhD, University 
Department of Dermatology and Venereology, Zagreb University 




For decades now, we are witnessing a great increase 
in the number of individuals who visit dermatologists 
hoping to reverse the signs of aging. The acquisition 
of new scientific concepts has been paralleled by novel 
scientific developments resulting in new therapeutic 
methods in corrective dermatology. A variety of anti-
aging products and medical interventions have been 
developed to improve the individual’s appearance. 
During the 1997-2007 period, the American Society 
for Aesthetic Plastic Surgery (ASAPS) has noticed 
a 448% increase in corrective procedures, including 
a 747% increase in non-surgical and 98% increase in 
surgical procedures.
Dermabrasion
Dermabrasion was one of the first therapeutic pro-
cedures in corrective dermatology. The skin is abraded 
to papillary layer of the dermis by use of a metal, dia-
mond or ruby grinder. After the procedure, remodel-
ing of collagen fibers in the dermis has been noticed 
by histologic examinations. 
Dermabrasion was introduced by Kromayer, and 
later developed by Schreus1. The procedure is usu-
ally performed to remove scars or reduce wrinkles. 
Dermabrasion may be performed under general or lo-
cal anesthesia, and the depth of abrasion depends on 
the indication. Postoperatively, healing usually occurs 
within seven to ten days. Patients are instructed to 
avoid sunlight for three to six months after the pro-
cedure, and to use sunscreen on a regular basis when 
outdoors. The possible complications include bacterial 
and viral infections, milia, scars and pigmentation ir-
regularities2. 
Chemical Peeling
Chemical peeling is a method by which concen-
trated chemicals are applied to the skin to peel off the 
dermis and epidermis. This results in regeneration of 
the dermis and epidermis with synthesis of new col-
lagenous and elastic fibers in the dermis. Chemical 
peeling is performed to remove acne and/or acne scars, 
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hyperpigmentation and signs of skin aging. Accord-
ing to the depth of peeling, chemical peel can be su-
perficial, medium depth and deep, depending on the 
chemical used, its concentration, and length of skin 
exposure3. Superficial peel implies epidermal peel to 
the dermoepidermal junction, mostly by use of alpha-
hydroxy acids, Jessner’s solution and trichloroacetic 
acid 10%-20%. The objective of treatment is to achieve 
keratolytic effect with fibroblast stimulation, thus im-
proving the skin texture, and reducing the number of 
comedones and hyperpigmentation4. Medium depth 
peel results in necrosis of the epidermis and part of 
or entire papillary layer of the dermis. The procedure 
is usually performed by use of tricholoroacetic acid at 
a concentration of 35%. The indications for medium 
depth peel include wrinkles, hyperpigmentation, 
shallow scars and signs of solar skin degeneration. 
Deep peel is used to remove deep scars. This proce-
dure results in necrosis of the epidermis and the entire 
papillary dermis, also involving the upper part of re-
ticular dermis. Deep peel is a demanding procedure 
that can only be carried out by experienced therapists 
using high concentrations of tricholoroacetic acid 35% 
or phenol solution (Baker-Gordon formula)3,5. 
Good patient selection is essential in obtaining 
clinical results. It is important to evaluate patient’s 
expectations and to have the patient’s written consent 
for the procedure. Ideal patient for chemical peeling is 
a fair complexion person with Fitzpatrick skin types 
I-II, while skin types IV-V are considered relative 
contraindications for this procedure. The most com-
mon complications are pigmentary anomalies. Milia, 
telangiectasias, prolonged erythema, infection, skin 
atrophy, texture changes and scars are among other 
possible complications. Postoperatively, proper skin 
care and photoprotection are essential3,6.
Lasers
Nowadays, corrective dermatology is almost in-
conceivable without the use of laser, one of the re-
cent methods of treatment that has been rapidly and 
continuously developing over the past few decades. 
The term laser is an acronym for “light amplification 
by the stimulated emission of radiation”. Laser light 
has unique properties that account for its therapeu-
tic activity: monochromaticity (the emitted light is of 
a single, discrete wavelength), coherence (laser light 
travels in phase with respect to both time and space) 
and collimation (emission of a narrow, intense beam 
of light in parallel fashion). Thus, laser light can be 
focused into small spot sizes allowing for precise tis-
sue destruction7.
The first laser was developed by Maiman in 1959, 
using monochromatic 694 nm ruby light. In 1963, 
dermatologist Dr Leon Goldman initiated ruby la-
ser treatment for a variety of cutaneous pathologies. 
Later, advances in laser technology have progressed 
rapidly, resulting in development of new laser sys-
tems with better therapeutic results and low risk of 
adverse effects8. Cutaneous laser surgery was revo-
lutionized in 1983, when Anderson and Parish pro-
posed the theory of selective photothermolysis. Ac-
cording to this theory, controlled destruction of target 
lesion with minimal damage to the adjacent tissues 
can be achieved under following conditions: first, the 
emitted wavelength must be absorbed preferentially 
by the intended target tissue or chromophore (mol-
ecules with unique absorption spectra, which are re-
sponsible for imparting color to substances); second, 
the energies produced by laser systems should be high 
enough to inflict thermal damage to the target; and 
third, the time of tissue exposure to the laser must be 
shorter than thermal relaxation time (defined as the 
time required for the target site to cool to one half to 
its peak temperature immediately after laser irradia-
tion). Based on these principles, laser parameters can 
be tailored to effect destruction of the tissue confined 
to microscopic site of selective light absorption in the 
skin, such as blood cells and pigmented cells, with 
minimal collateral thermal damage9.
Vascular lesions that are most frequently observed 
on aged skin include telangiectasias, cherry angiomas 
and venous lakes. The most commonly used lasers in 
treating these lesions include KTP (532 nm), Nd:YAG 
(532 and 1064 nm) and pulsed-dye laser (585-595 
nm)10.
Solar lentigines are the most common hypermel-
anotic lesions of photoaged skin. They occur from 
age 30 onwards as benign hyperpigmented lesions on 
chronically sun-exposed areas of the face, back of the 
hands and extensor surfaces of the forearms. To obtain 
selective photothermolysis of melanin, solar lentigines 
must be treated with laser light having a wavelength 
appropriate to absorption characteristics of melanin. 
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A variety of different laser systems that emit wave-
lengths of 500-1100 nm may be used to remove mel-
anin from the skin: the Q-switched ruby (694 nm), 
Q-switched alexandrite (755 nm) and Nd:YAG laser 
(532 and 1064 nm)11.
Cutaneous laser resurfacing represents the major 
advance in the treatment of severely pohotodamaged 
facial skin, photoinduced facial rhytides, dyschromias, 
and atrophic scars. Ablative laser resurfacing was in-
troduced in the 1980s with continuous-wave CO2 la-
sers, but their use was limited because of delayed heal-
ing and scarring. High-energy, pulsed, and scanned 
CO2 and Er:YAG lasers have been in widespread 
use since the mid-1990s for ablative resurfacing. The 
Er:YAG laser has a higher absorption coefficient in 
water-containing tissue; because 90% of the epidermis 
is composed of water, most of the energy of the er-
bium laser is superficially absorbed. The Er:YAG laser 
yields photomechanical tissue effect, whereas photo-
thermal tissue reaction is primarily effected by CO2 
treatment. However, the prolonged recovery time and 
a significant risk of postoperative hyper- and hypop-
igmentations, scars and other complications prompted 
to development of nonablative and fractional resur-
facing. Nonablative laser systems produce stimulation 
of collagen production and remodeling while preserv-
ing epidermis. This results in little or no healing time 
and less patient discomfort. The most commonly used 
lasers for nonablative resurfacing include pulsed dye 
laser (585-595 nm), Nd:YAG (1064 nm, 1320 nm), di-
ode (1450 nm) and Er:glass (1540 nm) laser. Fraction-
al resurfacing thermally ablates microscopic columns 
of epidermal and dermal tissue in regularly spaced ar-
rays over a fraction of skin surface. Each column is 
approximately 70-150 microns in width and 400-700 
microns in depth. Intervening areas of normal skin 
are left untouched, which rapidly repopulate the ab-
lated columns of the skin. This concept increases ef-
ficacy as compared to nonablative resurfacing but with 
faster recovery as compared to ablative resurfacing. For 
these reasons, fractional skin resurfacing is nowadays 
the most popular method of laser rejuvenation12,13.
Proper patient selection for laser resurfacing is es-
sential for obtaining successful procedure. Patients 
should be evaluated for their skin type according to 
the Fitzpatrick system; lower skin types (I-II) are at 
a low risk to develop postinflammatory hyperpigmen-
tation, whereas skin types IV-VI more often develop 
dyschromia. Patients with a personal history of pre-
vious cosmetic surgery may be predisposed to more 
fibrotic skin, while previous blepharoplasty increases 
the risk of ectropion. Postoperative scarring usually 
develops in patients with impaired wound healing 
from an underlying collagen vascular disease, im-
munodeficiency, or history of isotretinoin use within 
the past year. Special attention must be focused on 
patients with a history of labial herpes, bacterial or 
yeast infections, as medical prophylaxis is necessary in 
such cases. The presence of hyperelastic skin can lead 
to increased scaring, and the presence of hypertrophic 
or keloidal scars should be given consideration. Ab-
solute contraindications for laser resurfacing include 
isotretinoin use within 1 year of the procedure, con-
current bacterial or viral infection and ectropion. Pa-
tients with unrealistic expectations should be discour-
aged. Relative contraindications for laser resurfacing 
include a history of dyschromias, ongoing UV expo-
sure, hyperelastic or keloidal skin, history of radiation 
therapy, collagen vascular disease and prior cosmetic 
surgery (chemical peels, dermabrasion, laser surgery, 
and blepharoplasty). In order to minimize the risk 
of postinflammatory hyperpigmentation, sun avoid-
ance is recommended during 2 to 3 months postop-
eratively, and the use of broad-spectrum sunscreens is 
obligatory12,13. 
Intense Pulsed Light (IPL)
Intense pulsed light technology was developed in 
the early 1990s, initially for vascular lesions, then hair 
removal and pigment lesions, and today it is one of 
the standard procedures for photorejuvenation. In-
tense pulsed light emits the spectrum of wavelengths 
(550-1200nm), therefore targeting both melanin and 
hemoglobin, resulting in global improvement of dys-
pigmentation and vascularity. Intense pulsed light is 
able to induce remodeling of collagen and elastic fiber, 
without epidermal damage. The main advantage of 
this method is short recovery time and minimal risk 
of unwanted effects14. 
Radiofrequency
Radiofrequency is one of nonablative methods of 
rejuvenation, using devices that produce electrical en-
ergy that heats the dermis at relatively low tempera-
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tures. The result is collagen shrinkage and skin tight-
ening. New technologies combine radiofrequency and 
infrared laser or IPL, with better therapeutic results. 
The effects are visible after several treatment sessions. 
The main advantages include minimal postoperative 
erythema that resolves within few hours and lack of 
significant risk of side effects15.
Skin Implants (Fillers)
Skin implants or fillers are various substances in-
jected into the skin to fill in the wrinkles, atrophic 
scars and skin defects, and for face remodeling (lips, 
zygomatic region, chin and nose enlargement). Skin 
implants are classified according to the process of deg-
radation (biodegradable or non-biodegradable), origin 
(natural or synthetic), organic or inorganic character, 
and duration of effect (short-term, long-term or perma-
nent). Biodegradable implants include collagen (human, 
autologous, animal, stabilized ‘cross linked’ collagen), 
hyaluronic acid (animal, ‘non-animal’, stabilized-’cross 
linked’, non-stabilized) and hyaluronic acid in combi-
nation with other materials (dextran, lactic acid), and 
lactic acid (L-polylactic acid). Non-biodegradable fill-
ers include polymethylmethacrylate (PMMA), acrylate 
hydrogels, microspheres (60-90 microns) containing 
hyaluronic acid and zirconium, polyacrylamides, alkyl-
amides, methylsiloxanes, hydroxyapatite, and polytet-
rafluorethylene. An ideal implant should be safe and 
of optimal duration, simple to apply with minimal dis-
comfort, hypoallergenic and isovolemically degradable; 
upon treatment, the face should have natural appear-
ance, and the price of treatment should be acceptable. 
After all, the ideal effect means stimulation of own 
fibroblasts for the synthesis of own collagen. Unfortu-
nately, none of the agents available meets all the condi-
tions mentioned above16. 
Hyaluronic acid, a biodegradable implant, is cur-
rently most widely used because of its excellent thera-
peutic results associated with a very low risk of side 
effects. Therapeutic effect lasts for three months to 
two years in case of biodegradable implants, whereas 
non-biodegradable implants may last for years or even 
indefinitely. However, the application of non-biode-
gradable agents may be associated with the develop-
ment of foreign-body granulomas, pseudocysts and 
abscesses17.  
Botulinum Toxin
In addition to popular fillers, the clients show in-
creasing interest in the use of botulinum toxin to cor-
rect facial expression lines (around the eyes, between 
the eyebrows and forehead). Botulinum toxin is a po-
tent neurotoxin produced by the bacterium Clostridium 
botulinum, which causes temporary paralysis of stri-
ated muscles. The main precondition for therapeutic 
success is proper training and experience of the phy-
sician, who should have profound knowledge of the 
treated area anatomy, be sure in choosing correct indi-
cation and agent dosage, and using appropriate injec-
tion technique18. Therapeutic result in terms of wrin-
kle reduction can be observed within a week of the 
injection and lasts for several (4-12) months; the in-
terval between two procedures should be at least three 
months. Contraindications for this procedure include 
known hypersensitivity to any substance of the prod-
uct injected, systemic muscle disease (e.g., myasthenia 
gravis), concomitant use of aminoglycoside antibiotics 
and spectinomycin, infection at the site of injection, 
blood coagulation diseases, pregnancy and lactation. 
Adverse affects are rare and include paralysis of the 
adjacent muscles, e.g., m. levator palpebrae, resulting 
in ptosis of upper eyelid, which usually resolves in few 
weeks19. 
Current Trends: Combination of Different Corrective 
Procedures 
Recently, combinations of the methods listed above 
have been ever more employed to obtain the best aes-
thetic results.  For example, botulinum toxin and fill-
ers are commonly combined with chemical peeling, 
lasers and IPL.    
Conclusion
Nowadays, the most popular corrective proce-
dures are those with early visible results, minimal 
down-time after the procedure, with minimal risk 
of unwanted effects and complications (nonablative 
and fractional resurfacing instead of ablative, fillers, 
botulinum toxin, chemical peeling).  Proper choice of 
high quality treatments is the responsibility of derma-
tologist specialized in the field of corrective derma-
tology, especially in the light of the great number of 
new therapeutic options offered by fast technological 
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advancement. Unfortunately, these demanding cor-
rective treatments are ever more frequently performed 
at non-medical institutions and by incompetent per-
sons. Properly trained and experienced physician is 
fully aware of the crucial role of appropriate assess-
ment of the patient and his/her expectations. He will 
explain to him/her the corrective procedure, the po-
tential risks and the expected outcome. A predictable 
lack of patient compliance with proper skin care after 
the treatment and unrealistic expectations are con-
sidered absolute contraindications for any corrective 
treatment. 
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U posljednja dva desetljeća zabilježen je znatan razvoj u području korektivne dermatologije. Nova vrhunska postignuća 
u tehnikama i sve veće zanimanje za postupke podmlađivanja doveli su porasta broja korektivnih zahvata širom svijeta. U 
radu se prikazuju korektivni postupci koji se danas najčešće primjenjuju u dermatologiji, a to su laseri, intenzivno pulsno 
svjetlo, fileri, botulinski toksin, kemijski piling, radiofrekvencija i dermabrazija. Danas se prednost daje onim zahvatima 
kod kojih se razultati najbrže vide, koji imaju kratko vrijeme zastoja i minimalan rizik od neželjenih učinaka. Stoga je 
ablativno “presvlačenje” (resurfacing) uglavnom zamijenjeno neablativnim i frakcijskim “presvlačenjem”, dok se fileri i bo-
tulinski toksin rabe sve više. Najbolji kozmetski rezultati postižu se kombinacijom različitih korektivnih postupaka.
Ključne riječi: korektivna dermatologija, laseri, fileri, botulinski toksin, kemijski piling

